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Abstract
Background: Female genital mutilation/cutting (FGM/C) is a clear violation of women’s rights and can have
adverse and irreversible health effects as well. Worldwide, more than 200 million women and girls have undergone
FGM/C. Utility value of FGM/C has not been estimated yet, so we designed this study to extract the health utility
value of FGM/C for the first time in the world.
Methods: In a cross-sectional study in Iran, 125 girls and women who underwent FGM/C procedure were
examined by the trained midwives in order to determine its type. In addition, a questionnaire was completed for
identifying the socio-demographic factors and extracting the health utility of these individuals. Health utility was
measured using Time Trade-off method and also to determine the effects of the socio-demographic factors on the
health utility a two-limit censored regression model was applied.
Results: The mean and median of the health utility of women with FGM/C were 0.971 (SE: 0.003) and 0.968 (IQR:
1–0.95), respectively. Number of non-traders was 58 (46.4%) who reported perfect health utility. However, the mean
of health utility among traders was 0.946 (SE: 0.002). Only type 1 (Clitoridectomy) and type 2 (Excision) FGM/C were
seen in this study. Women with Type 1 FGM/C had significantly lower health utility value (Mean: 0.968, Median:
0.957) than their type 2 counterparts (Mean: 0.987, Median: 1.00). Moreover, women in the age group of 31–45
years (Mean: 0.962, Median: 0.956), single (Mean: 0.950, Median: 0.954), divorced (Mean: 0.951, Median: 0.950),
employed (Mean: 0.959, Median: 0.956), and with supplementary insurance (Mean: 0.962, Median: 0.950) had
significantly lower health utility than their counterparts.
Conclusion: FGM/C affects physical and psychological well-being of these individuals, resulting in a lack of personal
and marital satisfaction, which ultimately leads to a 3% reduction in their health related quality of life. Therefore,
preventing from this practice is very important and should be considered by health system policy makers more
than before.
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Background
Female Genital Mutilation/Cutting (FGM/C), which is
considered as a global concern, is defined by World
Health Organization (WHO) as “all procedures that in-
volve the partial or total removal of external genitalia or
another injury to the female genital organs for non-
medical reasons” [1]. The practice, which is also consid-
ered as violence against women, is prevalent in 30 Afri-
can and some Middle Eastern and Asian countries and
threatens the life of about 3.6 million girls and women
annually [2]. Estimates have shown that more than 200
million girls and women have experienced this counter-
human rights procedure [3].
The highest prevalence of FGM/C is seen in African
countries such as Somalia (98%), Guinea (96%), Djibouti
(93%), and Egypt (91%) [4]. It may also be seen among
some ethnic groups and immigrants living in developed
European and North American countries and Australia
[5]. Although there are no official and comprehensive
statistics on the prevalence of FGM/C in Iran, the results
of few studies have shown that the prevalence of the
practice varies by region and is mainly concentrated in
the western and southwestern provinces (Hormozgan,
Khuzestan, Bushehr, Kurdistan, and Kermanshah [6–8]
which are mostly inhabited by Sunni Muslims. The
prevalence of the FGM/C is reported to be between 55.5
and 70% primarily in rural of these areas [9, 10].
Researchers have divided the causes behind practicing
FGM/C into five groups: psychosexual, sociological and cul-
tural, hygienic and aesthetic, religious, and socio-economic
[11]. Some studies have shown that the main reasons for
performing this practice in Iran are the preservation of tra-
ditions, cleanliness, religious recommendations, and control
of sexual desire, respectively [8, 9]. These factors have
turned FGM/C, as an element for inequality and violence
against women, into a social norm or conviction [12]. How-
ever, so far, not only no hygienic or unsanitary benefits have
been reported for this procedure, but also numerous studies
have shown its increasing and long-term adverse effects. Its
immediate effects include shock, severe pain, extensive
bleeding, swelling, damage or infection of the genital area,
fever, and, in some cases, even death. Long-term effects of
FGM/C include urinary problems, vaginal problems (such
as discharge, infection and itching), menstrual problems,
scar tissue and keloid, sexual dissatisfaction, high-risk
pregnancy, psychological issues (depression, anxiety, post-
traumatic stress disorder, low self-esteem and self-
confidence), social isolation, and sanitation problems [2,
13–16]. However, the health-related quality of life of
women living with FGM/C has not been quantitatively
measured. Therefore, in this study, we aimed to measure its
utility value among different socio-demographic groups in
order to objectively determine the total effects of FGM/C
on health-related quality of life of women and girls.
Methods
Study population
This cross-sectional and multicenter study was con-
ducted in 2018 in Kermanshah province, west of Iran.
One hundred twenty-five females aged over 16 who had
experienced the FGM/C participated in the study after
giving their written consent. The samples were selected
by non-random consecutive sampling method from the
girls or women referred to the midwifery offices for
examination. Next, they were examined by trained mid-
wives, and a questionnaire was completed for them. An
obstetrician examined these women for having FGM/C
and identified its type.
Type 1 FGM/C (Clitoridectomy) means removing part
or all of the clitoris; type 2 (Excision) is defined as re-
moving part or all of the clitoris and the labia minora,
with or without removal of the labia majora; type 3 (in-
fibulation) is narrowing of the vaginal opening by creat-
ing a seal, formed by cutting and repositioning the labia;
and type 4 (other harmful procedures) means any injury
to the female genitals, including pricking, piercing, cut-
ting, scraping or burning the area. The females who did
not have any illness, disorder, and psychological disabil-
ity, except FGM/C entered the study.
Measurement of utility value
Time trade-off (TTO) approach has been used to meas-
ure the health-related utility of FGM/C. In this ap-
proach, the researcher asked the participants: how many
years in the current health state (X) you would be willing
to lose in order to regain full health. The number of
these years changes to the degree that the individual has
to subjectively stay indifferent between their health state
in remaining future years (Y) and perfect health state in
a shorter period of time and sees their value both the
same. The amount (x/y) is presented as disutility and the
result of formula 1- (x/y) indicates the health utility of
each individual. In all cases, in the first question, the
value of x was considered four years. If the interviewees
agree/disagree, this amount could be increased/de-
creased, and it continued until reaching the indifference
point. Life expectancy at birth for Iranian women was
considered 79 years.
The best and the worst health state of the individual
measured by TTO method equals zero and one, respect-
ively. It gets zero if the individual is not willing to lose
any years of their life, and it gets one if the individual is
willing to lose all their remaining years of life to fix the
FGM/C problem.
Measurement of socio-demographic characteristics
After determining the type of FGM/C, questions about
socio-demographic factors were asked from the partici-
pants by the midwife. These questions included
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determining the age (grouped in three classes: 19–30,
31–45, and over 46), marital status (single, married and
widowed/divorced), education (illiterate, high school
graduate, and university graduate), employment status
(unemployed, employed, and housewife), standardized
monthly household expenses (monthly household ex-
penditure is divided by its household dimension), and
having basic and supplementary health insurance.
The two-limit Tobit linear regression model was used
in order to determine the effects of socio-demographic
factors on the level of health utility among women with
FG/CM. In this model, given that the dependent variable
is assumed to have a normal distribution; therefore, we
considered the logarithmic value of health utility as a
dependent variable and factors of age (years of life); type
of FGM/C (1: type 2 and 0: type 1); marital status (1:
married and 0: non-married); education (number of
years of education); occupation (1: employed and 0:
non-employed); and standardized monthly household
expenditure (average monthly spending per person) as
independent variables. To determine the predictive vari-
ables in this model, some univariate logistic regressions
were performed for all socio-economics factors. Only pa-
rameters were selected that had a statistically significant
association with the dependent variable at 0.05 error
level. Pearson test for scale variables and Spearman test
for categorical variables were used to identify the auto-
correlation problem.
Statistical analysis
The distribution of studied women among socio-
demographic groups is represented by number and percent-
age. For each of these socio-demographic sub-groups, the
amount of measured utility has been reported with mean,
standard error, median, and interquartile range.
Due to the non-normal distribution of the utility
values, Kruskal Wallis (for groups with more than two
subgroups) and Mann-Whitney (for groups with two
subgroups) were used to measure the significant differ-
ence between the mean values for subgroups of each
socio-demographic group. The exchange rate used for
conversion is 1 USD = 120,000 Iranian Rials. The signifi-
cance level was set at a p-value < 0.05. All statistical ana-
lyzes were performed using STATA version 13 (Stata
Crop LP, College Station, TX, USA).
Ethical considerations
The Research Deputy of Kurdistan University of Medical
Sciences approved this study. Before the study, all partic-
ipants gave written informed consent to participate in
the study. The researchers adhered to the tenets of the
Declaration of Helsinki in the implementation of all
stages of the study.
Results
A total of 125 women and girls who had a history of
FGM/C participated in this study. The mean age of these
participants was 35.74 years (ranged 19–55). The partici-
pants included 10 (8%) single women, 17 (13.6%) di-
vorced / widowed, and the rest were married. The
distribution of first and second type of FGM/C among
the participants was 104 (83.2%) and 21 (16.8%), respect-
ively (Table 1).
The results of the Tobit regression analysis are pre-
sented in Table 2. As shown here, FGM/C disutility had
a significant positive relationship with the factors of hav-
ing a job, age, income and being single.
Discussion
The FGM/C procedure, which acts as a violation of
women’s rights and is considered as violence against
women, imposes much physical, psychosocial and social
harm on women and girls, and reduces their health-
related quality of life. For the first time, the current
study measured the utility value of FGM/C for different
socio-demographic groups. The results indicated that
women/girls living with FGM/C had an average health
utility of 0.971 (SE: 0.003) with a median of 0.968 (IQR:
1–0.95). In other words, they lost about 3% of their
Health-Related Quality of Life (HRQoL) due to FGM/C,
on average.
Generally, the results of the regression model and uni-
variate analysis were highly consistent, except for the
education level. These findings confirm that the value of
FGM/C disutility is positively and significantly associated
with age, income level, having a job, and not having a
husband. Univariate analysis indicates a statistically sig-
nificant association between FGM/C disutility and edu-
cation years, but this relationship is not confirmed by
multivariate analysis. Of course, these results need to be
interpreted with caution, which are discussed below.
The utility value, which subjectively represents the
sum of the effects of FGM/C on women’s health, was
statistically significantly lower for single (Mean: 0.950,
Median:0.954) and divorced women (Mean: 0.951, Me-
dian: 0.950) compared to married women (Mean: 0.977,
Median:1.00). In other words, single and divorced
women experienced more reduction in their HRQoL
than married women. This finding is confirmed in both
univariate and multivariate analysis models. One pos-
sible explanation for this finding is that FGM/C practice
delayed marriage for the circumcised single women, as
the mean age of them was significantly higher than their
married counterparts (38.2 vs. 33.8 years). Besides, it
could conceivably be hypothesized that FGM/C, due to
its psychosexual problems [11], is a crucial factor in the
decision to divorce and thereby increasing the disutility
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of the practice, which is an important issue for future
research.
This negative effect may vary in different countries
and cultures, as in countries such as Nigeria, Somalia,
and Sudan, girls who have performed FGM/C have a
higher chance of finding a partner and having a timely
marriage [17, 18]. While in Guinea, having or not having
FGM/C, did not have any effect on the chance of getting
married [19]. While Iran has a much more open society
and prevalent interracial marriage than African and
other Middle East countries, unlike these countries, per-
forming the FGM/C does not necessarily increase the
chance of marriage. FGM/C practice, which is per-
formed only among a part of Sunni minority living in
the western border areas of Iran, is generally considered
Table 1 Utility values of Female Genital Mutilation among different socio-economic groups
Socio-Demographic




valueMean (SE) Median (IQR)
Total 125 (100) 0.971 (0.003) 0.968 (1–0.950)
Age 0.001
Young (19–30 years) 42 (16.0) 0.978 (0.004) 1.000 (1–0.968)
Not Young (31–45 years) 63 (50.4) 0.962 (0.003) 0.956 (1–0.936)
Middle age (46–55 years) 20 (33.6) 0.985 (0.005) 1.000 (1–0.950)
Marital Status 0.003
Single 10 (8,0) 0.950 (0.006) 0.954 (0.957–0.936)
Married 98 (78,4) 0.977 (0.003) 1.000 (1–0.956)
Divorced 17 (13.6) 0.951 (0.001) 0.950 (0.950–0.950)
FGM/C types 0.051
Clitoridectomy 104 (83.2) 0.968 (0.013) 0.957 (1–0.943)
Excision 21 (16.8) 0.987 (0.014) 1.000 (1–0.968)
Education 0.009
Illiterate 39 (31.2) 0.981 (0.005) 1.000 (1–0.956)
High school 32 (25.6) 0.967 (0.004) 0.950 (1–0.950)
University 54 (43.2) 0.967 (0.004) 1.000 (1–0.956)
Job 0.023
Employed 16 (12.8) 0.959 (0.027) 0.956 (0.979–0.941)
Unemployed 33 (26.4) 0.963 (0.004) 0.950 (1–0.950)
Housewife 76 (60.8) 0.978 (0.030) 1.000 (1–0.956)
Having basic insurance 0.203
Yes 105 (84,0) 0.970 (0.029) 0.958 (1–0.950)
No 20 (16,0) 0.979 (0.06) 0.992 (1–0.968)
Having Supplementary insurance 0.024
Yes 34 (27.2) 0.962 (0.028) 0.950 (1–0.950)
No 91 (72.8) 0.975 90.028) 1.000 (1–0.952)
Standardized household’s monthly cost 0.077
Lowest (< 50 USD) 111 (88.8) 0.970 (0.029) 0.968 (1–0.950)
Highest (> 50 USD) 14 (11.2) 0.984 (0.026) 1.000 (1–0.956)
SE Standard error, IQR Interquartile range
Table 2 Estimation results of the two-limit Tobit model of utility
value for Female Genital Mutilation
Variables Coefficient t statistics P-value
Age 0.008 2.45 0.021
FGM/C types 0.037 2.79 0.096
Marital status 0.005 2.61 0.014
Education −0.003 −0.60 0.553
Job 0.007 2.20 0.030
Standardized monthly expenditure 0.035 2.14 0.034
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as an abominable and unacceptable practice from
society’s point of view. So, performing this practice even
may decrease the marriageability. Nonetheless, a defini-
tive answer to this requires more in-depth studies [20].
Another reason can be related to the perception of sin-
gle women of marital restrictions of FGM/C, such as
intercourse pain, less sexual pleasure and related bleed-
ing. Since women from less developed societies may not
experience these restrictions before marriage, they may
over-estimate them [17]. The divorced women may also
attribute their separation and failure in life to FGM/C.
Another important result of this study was that
women in the 31–45 age group statistically significantly
reported a lower HRQoL (Mean: 0.962, Median: 0.956)
than others. The reason could explain this finding is that
middle-aged women are more likely to have experienced
the adverse effects of the FGM/C than their younger
counterparts, and they also have higher expectations of
the quality of their sexual relations than their adult
peers. However, further analysis of the data showed that
the middle-aged group had the highest divorce rate than
others, accounting for 69% of all divorces. This result
could support the theory, as mentioned earlier, that
FGM/C could be a risk factor for divorce. This finding is
in line with the results of other studies [21–24].
Unexpectedly findings showed that employed subjects
reported less health utility than unemployed women and
housewives (Mean: 0.959, Median: 0.956). It is difficult
to explain this result, but with more analysis, we find
that the average years of education in this group were
significantly higher than in other groups so that all 16
members of this group had a university degree. There-
fore, the difference in their level of disutility may be
more due to their level of education, not their employ-
ment status. To study the association between employ-
ment factor and HRQoL of women with FGM, a larger
sample size that enables us to control factors such as
age, marital status, and degree of education are required,
and this study is not able to give an accurate answer in
this regard.
In this study, only FGM/C types 1 and 2 have been
seen, and due to the very low prevalence of other more
severe types of the practice, we have not found them [8].
Although we know that FGM/C type 2 is much more in-
vasive, painful, and has more side effects than type 1,
surprisingly, our findings showed that FGM/C type 1
had higher disutility value than another. Of course, it
should be noted that this difference was not statistically
significant in any of the analytical models. Since the
group with FGM/C type 2 had higher age means than
type 1 (37.47 vs. 27.14) and were completely different in
terms of marital status (all participants who have never
been married or divorced were in type 1 group), we are
not allowed to compare their health utility values.
Therefore, to more accurately compare the effects of
type of FGM/C on HRQoL, a larger sample size with the
same age strata is required for all types of FGM/C.
Fifty-eight participants of the study (46.4%) were not
willing to lose any time to regain their usual genital con-
dition, and they reported a full health utility. These are
referred to as non-traders. All of them were married,
and more than 81% of them were housewives. These
people, on average, had a larger household size with a
monthly household expenditure below the average.
Therefore, it can be concluded that non-traders were
less influenced by the effects of FGM/C, and were able
to live their lives following the community conditions
and their expectations, so they did not complain about
it. The mean health utility for traders was 0.946 (95% CI:
0.943–0.950). In other words, women, who have been
hurt in their personal and family life due to FGM/C, lose
5.4% of their HRQoL.
We know that the effects of FGM/C, which violates
women’s rights, are not limited to their health and
HRQoL, but their individual and social lives. According
to the findings, if we consider only the HRQoL effects,
FGM/C can be compared with diseases such as non-
severe hypoglycemic, mild primary dysmenorrhea, skin
neoplasm, myopia, and otitis media associated with pain.
On average, these all result in a 3% loss of HRQoL in in-
dividuals. Subgroups such as single or middle-aged
women with FGM/C, who are affected by this procedure
more than others, have disutility almost equal to mild
gastroenteritis. Of course, since the FGM/C procedure is
mainly performed during the childbirth or childhood, it
has life-time effects and imposes more disease burden
than the diseases as mentioned earlier (Table 3). If we
assume that a girl performs FGM/C in her first year of
life, with a discount rate of 3% and a life expectancy of
75 years, its burden of disease is equal to 0.87 years.
The burden of FGM/C is unnecessary and avoidable,
provided that governments take indigenous and effective
Table 3 Comparison of FGM’s utility value with other diseases







Stable schizophrenia 0.919 [26]
Mild Primary Dysmenorrhea 0.970 [27]





Otitis media with pain 0.970 [31]
Moderate gastroenteritis 0.940 [31]
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initiatives and measures to prevent the FGM/C proced-
ure. To develop domestic protocols, the main reasons
for performing FGM/C should be extracted in each
community and should be considered as a basis for iden-
tifying prevention strategies.
Numerous studies have shown that the social factors
that determine the performance of FGM/C vary from
country to another, which requires different policies to
control this practice. Snow et al. introduced ethnicity,
age, religion, and education as the most critical social
predictors of FGM/C in Nigeria [32], which had a high
consistent with Ofori-Fosu’s findings in Ghana [33].
Bogale et al. concluded that the main reasons for the
perpetuation of this practice in Ethiopia were religion,
safeguarding virginity, tradition, and social values, re-
spectively [34]. Ouedraogo, meanwhile, sees social pres-
sure as the main reason for the decision to practice
excision in Burkina Faso households [35]. According to
Afifi’s findings in Egypt and Satti et al. In Sudan, low
levels of education were the main culprits for FGM,
which with the increase in the level of education,
women’s desire to continue this practice has significantly
decreased for their daughters [36, 37].
Of course, all prevention programs require intersec-
toral collaboration and should include activities such as
health education to parents, passing national laws, stand-
ing against some meaningless social norms and trad-
itional beliefs, encouragement of mothers and girls to
educate, and getting help from religious missionaries
[38, 39]. Nowadays, one of the new barriers to eliminate
FGM/C in some countries, especially African countries,
is medicalization. Doctors, nurses, and some other
health workers claim that they can perform this proced-
ure on sanitary conditions, so they give FGM/C legitim-
acy. It not only does not help the prevention of FGM/C,
but it also encourages people to do it. Therefore, an-
nouncing that performing FGM/C is against the law can
also be a useful step to reduce the incidence of this pro-
cedure [40, 41].
The strength of the current study was to examine
FGM/C victims by trained midwives to determine the
degree of FGM/C. However, the results of the present
study should be interpreted in light of its limitations.
First, we did not include types 3 and 4 of FGM/C; there-
fore, our results can only be generalized to women with
types 1 and 2. Given the fact that the more severe types
of this disorder impose more long-term adverse effects
on the individuals and create more family and personal
problems for them, it may also generate greater health
disutility. Therefore, it is highly recommended that the
disutility of FGM/C types 3 and 4 should be extracted in
other studies. Second, the value of health disutility of
FGM/C seems to be very much influenced by the culture
of the community, so if the restrictions imposed by
FGM/C prevent women from meeting their personal
and social expectations, it can raise women’s dissatisfac-
tion and create more disutility. Therefore, the results of
this study are not necessarily the same in different soci-
eties and communities.
Conclusion
Iranian women undergoing FGM/C types 1 and 2 lose
an average of 3% of their HRQoL due to their health
problems. Of course, this figure for non-traders and
traders is estimated as zero and 5.5%, respectively.
Therefore, the epidemiological burden of FGM/C is very
considerable, and it is recommended that the countries
involved in this social and health challenge develop pre-
vention protocols for FGM/C and stick at them
seriously.
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